Steen Lisby
Geen lopende functies
Vermogen: 528 304 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Steen Lisby
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
24
| Public Company | Pharmaceuticals: Major | 24 |
| Public Company | Pharmaceuticals: Major | 12 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Steen Lisby via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CARDINAL HEALTH, INC. | Medical Distributors | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal | |
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Investment Managers | Private Equity Investor | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
Nasdaq Copenhagen A/S
 Nasdaq Copenhagen A/S Investment Banks/BrokersFinance Nasdaq Copenhagen A/S operates as a stock exchange. Its listed securities cover financial instruments such as shares, bonds, and money market instruments like treasury bills and notes. The company was founded in 1919 and is located in Copenhagen, Denmark. | Investment Banks/Brokers | Corporate Officer/Principal | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| COPENHAGEN CAPITAL A/S | Real Estate Development | Director/Board Member | |
Catalent USA Packaging LLC
 Catalent USA Packaging LLC Pharmaceuticals: MajorHealth Technology Part of Catalent, Inc., Catalent USA Packaging LLC is a company based in Somerset, NJ. The CEO of the company is John W. Lowry. | Pharmaceuticals: Major | Director of Finance/CFO | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SUN PHARMACEUTICAL INDUSTRIES LTD. | Pharmaceuticals: Major | Director/Board Member | |
| GLENMARK PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
CIS Bio International SA
 CIS Bio International SA Pharmaceuticals: MajorHealth Technology CIS Bio International SA engages in the distribution of radiopharmaceuticals for diagnosis and therapy. The company is headquartered in Saclay, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pharmaceutical Development Center
 Pharmaceutical Development Center Miscellaneous Commercial ServicesCommercial Services Part of AAIPharma, Inc., Pharmaceutical Development Center researches and develops pharmaceutical products. The company is based in Charlotte, NC. Pharmaceutical Development Center was acquired by AAIPharma, Inc. on July 31, 2001. | Miscellaneous Commercial Services | Public Communications Contact | |
| Fairleigh Dickinson University | College/University | Graduate Degree | |
| New York University | College/University | Corporate Officer/Principal | |
| Universität zu Köln | College/University | Graduate Degree Doctorate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Masters Business Admin | |
| University of Aarhus | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree | |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Director/Board Member | |
Association of Chartered Certified Accountants
 Association of Chartered Certified Accountants Miscellaneous Commercial ServicesCommercial Services The Association of Chartered Certified Accountants (ACCA) is a professional body for accountants. The non-profit company is based in Glasgow, UK, and has subsidiaries in Mauritius, United Kingdom, and Hong Kong. The British company offers a program called ALP-C, which approves learning materials from high-quality content providers to support studying towards ACCA's qualification. The role of the CFO is evolving beyond finance to include reporting on value-centric aspects of their operations, as companies move towards sustainable practices. The CEO of the company is Helen Joanna Brand. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Swindon College | College/University | Undergraduate Degree | |
| St. John's College, Cambridge | College/University | Graduate Degree | |
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Founder | |
| Prospect AS | Director/Board Member | ||
| Stephen M. Ross School of Business | College/University | Masters Business Admin | |
| City University London | College/University | Graduate Degree | |
| Riddersalen Theater | Chairman | ||
| VICORE PHARMA HOLDING AB | Pharmaceuticals: Major | Director/Board Member | |
| NUCANA PLC | Biotechnology | Director/Board Member Director/Board Member | |
Larix A/S
 Larix A/S Medical/Nursing ServicesHealth Services Larix A/S provides pharmacovigilance services. It offers statistics, data management, clinical operations, laboratory audits, data protection trainings, as well as medical writing. The company was founded by Klaus Juel Olsen and Grete Ulla Stærkind on November 7, 2001 and is headquartered in Herlev, Denmark. | Medical/Nursing Services | Chairman | |
| CATALENT, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Michigan Medical School | College/University | Doctorate Degree | |
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Medical Distributors | Director/Board Member | |
Ferring Holding, Inc.
 Ferring Holding, Inc. Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, Ferring Holding, Inc. is a company that manufactures and sells pharmaceuticals. The company is based in Parsippany, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Catalent Germany Schorndorf GmbH
 Catalent Germany Schorndorf GmbH Pharmaceuticals: MajorHealth Technology Part of Catalent, Inc., Catalent Germany Schorndorf GmbH is a pharmaceutical manufacturing company. The company is based in Schorndorf, Germany. The CEOs of the company are Thilo Widmayer, Roel de Nobel, Barry B. Littlejohns, Wetteny Joseph. | Pharmaceuticals: Major | Chief Executive Officer | |
| CESSATECH A/S | Pharmaceuticals: Major | Director/Board Member | |
Semdor Pharma Group GmbH
 Semdor Pharma Group GmbH Pharmaceuticals: MajorHealth Technology Semdor Pharma Group GmbH is a German pharmaceutical company that specializes in narcotics and medical cannabis. With the merger of Cannamedical Pharma and PS Pharma, it is the only full-service pharmaceutical narcotics company in Germany that has its own medical cannabis brand and sales team. Semdor Pharma Group is the leading pharmaceutical company for narcotics and medical cannabis in Germany. | Pharmaceuticals: Major | Director/Board Member | |
| Trizell Holding SA | Director/Board Member | ||
| Dessau-Rosslau | Real Estate Development | Director/Board Member | |
IDT Biologika GmbH
 IDT Biologika GmbH Pharmaceuticals: MajorHealth Technology IDT Biologika GmbH manufactures and distributes vaccines and biopharmaceuticals for the protection of human and animal health. The firm offers development services and manufacturing facilities for clinical phase I to III as well as commercial supplies for viral and bacterial human and animal health vaccines. The company was founded on July 1, 1921 and is headquartered in Dessau-Rosslau, Germany. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 18 |
| Denemarken | 14 |
| Verenigd Koninkrijk | 8 |
| Duitsland | 6 |
| Zwitserland | 3 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 13 |
| Finance | 5 |
| Commercial Services | 4 |
| Distribution Services | 3 |
Operationeel
| Director/Board Member | 167 |
| Corporate Officer/Principal | 64 |
| Independent Dir/Board Member | 58 |
| Chairman | 25 |
| Director of Finance/CFO | 20 |
Sterkste connecties
- Beurs
- Insiders
- Steen Lisby
- Bedrijfsconnecties
